Gupta Gayatri, Aronow Wilbert S
Department of Medicine, Geriatrics Division, New York Medical College, Valhalla, 10595, USA.
J Am Med Dir Assoc. 2003 Jul-Aug;4(4):200-2. doi: 10.1097/01.JAM.0000073963.49915.FC.
To investigate the prevalence of osteoporosis, the prevalence of utilization of bone mineral density (BMD) measurements for diagnosis of osteoporosis, and prevalence of use of calcium and vitamin D supplements and other antiresorptive therapies for treatment of osteoporosis in postmenopausal women in an academic nursing home.
The charts of all women aged 56 years and older residing in an academic nursing home were analyzed by one of the authors for the prevalence of osteoporosis, the prevalence of use of BMD measurements to diagnose osteoporosis, and the prevalence of use of calcium and vitamin D supplements and other antiresorptive therapies for treatment of osteoporosis.
Of 136 postmenopausal women, mean age 79 +/- 10 years, 66 (49%) had measurements of BMD. Of these 66 women, 31 (47%) had osteoporosis, 21 (32%) had osteopenia, and 14 (21%) had normal BMD. Elemental calcium carbonate 1500 mg daily was prescribed to 17 of 31 women (55%) with osteoporosis, to 12 of 21 women (57%) with osteopenia, to 2 of 14 women (14%) with normal BMD, and to 27 of 70 women (39%) with no BMD obtained. Any dose of calcium was prescribed to 78 of 136 elderly women (58%). Vitamin D supplements were prescribed to 13 of 31 women (42%) with osteoporosis, to 9 of 21 women (43%) with osteopenia, to 2 of 14 women (14%) with normal BMD, and to 20 of 70 women (29%) with no BMD obtained. Vitamin D supplements were prescribed to 44 of 136 elderly women (32%). Biphosphonates were prescribed to 19 of 31 women (61%) with osteoporosis. Of 20 women on medications that increased the risk of osteoporosis, 6 (30%) had BMD measured. Nine of these 20 women (45%) were on calcium supplements.
Older postmenopausal women in an academic nursing home have a high prevalence of osteoporosis and osteopenia, a low prevalence of measurement of BMD, and underuse of calcium, vitamin D supplements, and other antiresorptive therapies for treatment of osteoporosis.
调查一所学术型养老院中绝经后女性骨质疏松症的患病率、利用骨密度（BMD）测量诊断骨质疏松症的患病率，以及使用钙和维生素D补充剂及其他抗吸收疗法治疗骨质疏松症的患病率。
由一位作者分析了一所学术型养老院中所有年龄在56岁及以上女性的病历，以了解骨质疏松症的患病率、使用BMD测量诊断骨质疏松症的患病率，以及使用钙和维生素D补充剂及其他抗吸收疗法治疗骨质疏松症的患病率。
在136名绝经后女性中，平均年龄为79±10岁，66名（49%）进行了BMD测量。在这66名女性中，31名（47%）患有骨质疏松症，21名（32%）患有骨质减少症，14名（21%）BMD正常。31名患有骨质疏松症的女性中有17名（55%）被开具每日1500毫克元素碳酸钙的处方，21名患有骨质减少症的女性中有12名（57%），14名BMD正常的女性中有2名（14%），70名未进行BMD测量的女性中有27名（39%）。136名老年女性中有78名（58%）被开具了任何剂量的钙。31名患有骨质疏松症的女性中有13名（42%）被开具维生素D补充剂，21名患有骨质减少症的女性中有9名（43%），14名BMD正常的女性中有2名（14%），70名未进行BMD测量的女性中有20名（29%）。136名老年女性中有44名（32%）被开具维生素D补充剂。31名患有骨质疏松症的女性中有19名（61%）被开具双膦酸盐。在20名服用增加骨质疏松症风险药物的女性中，6名（30%）进行了BMD测量。这20名女性中有9名（45%）服用钙补充剂。
一所学术型养老院中的老年绝经后女性骨质疏松症和骨质减少症的患病率较高，BMD测量的患病率较低，且钙、维生素D补充剂及其他抗吸收疗法在治疗骨质疏松症方面使用不足。
